BCG vaccine

(redirected from Calmette-Guerin vaccine)
Also found in: Dictionary, Encyclopedia.
Related to Calmette-Guerin vaccine: bacillus Calmette-Guerin, bacille Calmette-Guérin vaccine

BCG vaccine

 
bacille calmette-guérin vaccine, a tuberculosis vaccine containing living, avirulent, bovine-strain tubercle bacilli (Mycobacterium bovis). It may be administered percutaneously by a special technique using a multiple-puncture disk, intracutaneously, or intradermally, and it cannot be given when the patient is reactive to tuberculin, when acute infectious disease is present, or when there is extensive skin disorder. It offers some protection against tuberculosis but cannot be relied on for total control of the disease. In a high percentage of cases the vaccine causes local ulcers at the site of administration. Public health officials in the United States recommend the use of BCG vaccine only for those persons living in communities having a high rate of tuberculosis cases. After vaccination with BCG, the patient will have a positive response to tuberculin tests. See also BCG solution.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

BCG vac·cine

a suspension of an attenuated strain (bacillus Calmette-Guérin) of Mycobacterium tuberculosis, bovine type, which is inoculated into the skin for tuberculosis prophylaxis.
Synonym(s): bacillus Calmette-Guérin vaccine, Calmette-Guérin vaccine, tuberculosis vaccine
Farlex Partner Medical Dictionary © Farlex 2012

BCG vaccine

(bē′sē-jē′)
n.
A preparation consisting of attenuated human tubercle bacilli that is used for immunization against tuberculosis.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.

BCG vaccine

A vaccine containing Bacille Calmette-Guérin, an attenuated strain of the bovine tubercle bacillus. The vaccine is used to confer a measure of immunity on people who, on Mantoux or Heaf testing are shown not to have had a primary infection with tuberculosis. It is equally effective in giving protection against leprosy. BCG vaccine is available in a freeze-dried form. The drug is on the WHO official list. (Leon Charles Albert Calmette, 1863–1933, French surgeon, and Camille Guerin, 1872–1961, French veterinary surgeon).
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005

Calmette,

Leon Charles Albert, French bacteriologist, 1863-1933.
Bacille bilié de Calmette-Guérin - an attenuated strain of Mycobacterium bovis used for immunization against tuberculosis and in cancer chemotherapy. Synonym(s): Bacille Calmette-Guérin; Calmette-Guérin bacillus
Bacille Calmette-Guérin - Synonym(s): Bacille bilié de Calmette-Guérin
bacillus Calmette-Guérin vaccine - a vaccine for tuberculosis prophylaxis. Synonym(s): BCG vaccine
Calmette test - conjunctival reaction to tuberculin.
Calmette-Guérin bacillus - Synonym(s): Bacille bilié de Calmette-Guérin
Calmette-Guérin vaccine - Synonym(s): bacillus Calmette-Guérin vaccine
Medical Eponyms © Farlex 2012
Mentioned in ?
References in periodicals archive ?
Saving lives by training innate immunity with bacilli Calmette-Guerin vaccine. PNAS.
Nonspecific effects of vaccination
* The original EPI vaccines were Bacille Calmette-Guerin vaccine (BCG) (to protect against tuberculosis), polio vaccine (Pol), measles-containing vaccine (MCV), and diphtheria-tetanus-pertussis vaccine (DTP).
Global routine vaccination coverage, 2015
Since 1974, global coverage with the four core vaccines (Bacille Calmette-Guerin vaccine [BCG; for protection against tuberculosis], diphtheria-tetanus-pertussis [DTP] vaccine, poliovirus vaccine, and measles vaccine) has increased from <5% to [greater than or equal to]85%, and additional vaccines have been added to the recommended schedule.
Global routine vaccination coverage, 2014
Since then, global coverage with the four core vaccines (Bacille Calmette-Guerin vaccine [for protection against tuberculosis], diphtheria-tetanus-pertussis vaccine [DTP], polio vaccine, and measles vaccine) has increased from <5% to [greater than or equal to]84%, and additional vaccines have been added to the recommended schedule.
Global routine vaccination coverage, 2013
We were a bit disappointed that Bacille Calmette-Guerin vaccine was covered in only seven lines, that bed nets were not mentioned for malaria control, that typhoid was not included in the differential diagnosis of lymphocytosis or prolonged fever, that short-course therapy was not recommended for typhoid fever, and that tinidazole or single-dose metronidazole were not suggested for invasive amebiasis.
Oxford Handbook of Tropical Medicine
Worldwide coverage with other recommended vaccines was 89% for bacille Calmette-Guerin vaccine, 84% for the third dose of poliovirus vaccine, 84% for the first dose of measles-containing vaccine, 79% for the third dose of hepatitis B vaccine, and 45% for the third dose of Haemophilus influenzae type b vaccine.
Global routine vaccination coverage--2012
Initially, those vaccines were limited to bacille Calmette-Guerin vaccine (BCG), diphtheria-tetanus-pertussis vaccine (DTP), oral poliovirus vaccine, and measles-containing vaccine (MCV).
Global routine vaccination coverage, 2011
Coverage with the other routinely recommended childhood vaccines was 90% for Bacille Calmette-Guerin vaccine, 86% for the third dose of poliovirus vaccine, 85% for measles-containing vaccine, 75% for the third dose of hepatitis B vaccine, and 42% for the third dose of Haemophilus influenzae type b vaccine.
Global routine vaccination coverage, 2010
This lack of understanding as to what constitutes an appropriate birth dose of HepB vaccine might reflect the fact that the term "birth dose" also is used widely for bacille Calmette-Guerin vaccine administration a few weeks after birth, and for oral poliovirus vaccine administration several days after birth.
Implementation of newborn hepatitis B vaccination--worldwide, 2006
Countries should validate coverage regularly through house-to-house monitoring and/or comparing the number of measles vaccine doses administered to the number of first doses of DTP or the number of doses of Bacille Calmette-Guerin vaccine; 2) Performing follow-up campaigns at least every 4 years and achieving [greater than or equal to]95% vaccination coverage in all municipalities.
Progress Toward Interrupting Indigenous Measles Transmission -- Region of the Americas, January 1999-September 2000
Children aged 0-2 months received Bacillus Calmette-Guerin vaccine, those aged 2-9 months received oral poliovirus vaccine (OPV) and diphtheria and tetanus toxoids and pertussis vaccine (DTP), and children aged 9-48 months received OPV and measles vaccine.
Vaccination Campaign for Kosovar Albanian Refugee Children -Former Yugoslav Republic of Macedonia, April-May, 1999
In addition, approximately one third of vaccination posts administered additional vaccines recommended by WHO's Expanded Program on Immunization (EPI) to eligible persons based on review of their vaccination records; these vaccines included measles vaccine, bacilie Calmette-Guerin vaccine, and diphtheria and tetanus toxoids and pertussis vaccine for young children and tetanus toxoid for women aged 15-44 years.
National immunization days and status of poliomyelitis eradication - Philippines, 1993

Medical browser ?
Full browser ?